Clinical Trials Browser

OTHER × Has results × ostarine × Clear all

NCT02971761 2024-02-20

Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer

Phase 2 Completed

18 enrolled 17 charts

Triple Negative Breast Neoplasms